NO20030153L
Use of a solubility enhancing component in an aqueous composition comprising brimonidine tartrate
Abstract
The invention relates to an aqueous composition comprising a solution of: a quinoxaline component; a solubility enhancing component selected from the group consisting of carboxymethyl cellulose and mixtures thereof; and a liquid carrier component, whereby the following composition is excluded:
Term
No projected expiry on record.
- Priority
- Filed and published
- Today
8 priority claims, no other members on record
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 21820600 | United States of America | P | |
| 21820600 | United States of America | P | |
| 0121551 | United States of America | W | |
| 0121551 | United States of America | W | |
| 0121551 | – | – | – |
| 218206 | – | – | – |
| US20000218206P | – | – | – |
| WO2001US21551 | – | – | – |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Patent expiredExpiredMK1K | MK1K |
Numbers
- Publication, DOCDB
- 20030153
- Publication, EPODOC
- NO20030153L
- Application
- 153
- Application, DOCDB
- 20030153
- Application, EPODOC
- NO20030000153
Titles2
- Norwegian
- Blandinger som inneholder terapeutisk aktive komponenter som har foröket löselighet
- English
- Mixtures containing therapeutically active components which have increased solubility
Classification
- CPC, 8
- A61K9/0048
- A61K47/00
- A61K31/4164
- A61K31/498
- A61P25/02
- A61P27/00
- A61P27/02
- A61P43/00
- IPC, 18
- A61K9 00
- C07D241 42
- A61K9 08
- A61K31 4164
- A61K31 498
- A61K47 02
- A61K47 04
- A61K47 12
- A61K47 14
- A61K47 18
- A61K47 32
- A61K47 36
- A61K47 38
- A61K47 42
- A61P25 02
- A61P27 02
- A61P43 00
- C07D403 12